Clinical Trial Update: EXIT: Prospective Study of the Response to Exercise

View source ↗

Summary

The EXIT trial, a prospective study evaluating the response to exercise, has completed in participants with fatty liver disease and type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Manitoba | Conditions: Liver Fat, Type 2 Diabetes | Status: COMPLETED